Baidu
map

全新“液体活检”芯片可以通过一滴血检测出转移性癌症

2017-01-04 佚名 来宝网

伍斯特理工学院的工程师们研究出一种全新的芯片,只需要用癌症患者体内的一滴血就可以检测出确定转移性癌细胞。 这一消息的惊人之处就在于其使用简单的方法带来了科技的又一飞跃。 根据《科学新闻日报》登载的所示,比起现有使用微流体诱捕癌细胞,这一全新的技术更加有效。 伍斯特理工学院的的研究小组成员解释说,这一设备就好像一口小井,井底的碳纳米管上附着着抗体,癌细胞来到井底,根据表面标记选择性的连接

伍斯特理工学院的工程师们研究出一种全新的芯片,只需要用癌症患者体内的一滴血就可以检测出确定转移性癌细胞。

这一消息的惊人之处就在于其使用简单的方法带来了科技的又一飞跃。

根据《科学新闻日报》登载的所示,比起现有使用微流体诱捕癌细胞,这一全新的技术更加有效。

伍斯特理工学院的的研究小组成员解释说,这一设备就好像一口小井,井底的碳纳米管上附着着抗体,癌细胞来到井底,根据表面标记选择性的连接在抗体上,接着他们制作了名为“外来体”的细微小结构,这就是他们捕捉癌细胞的方法。

《纳米科技》中详尽介绍了“液体活检”的报告,这一全新科技将成为最简单的实验室实验,可以帮助检测出癌症转移的早期阶段,使医生更快更准确的进行治疗。

众所周知,癌细胞会通过一个器官转移到其他器官,转移的过程都是通过血液进行的,然而不同的癌症转移的器官也不尽相同。

比如,乳腺癌更容易转移到肺部,大脑或骨头中,如果可以早期判断出癌细胞转移的方向,那么再进一步恶化之前就可以采取措施。

目前存在的问题是,一小部分癌细胞漂浮在无数的红细胞和白细胞之间。不过,研究小组成员肯定了他们技术的高精准度。

原文检索《New 'Liquid Biopsy' Chip Can Detect Metastatic Cancer With a Drop of Blood》

相关会议推荐


2017液体活检产业发展论坛

会议时间:2017.4.27-2017.4.28      会议地点:上海

会议详情: http://www.bioon.com/z/2017liquid/

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2010765, encodeId=144a2010e654f, content=<a href='/topic/show?id=98de9341975' target=_blank style='color:#2F92EE;'>#转移性癌症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93419, encryptionId=98de9341975, topicName=转移性癌症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Jan 22 09:21:00 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277998, encodeId=52d412e79982a, content=<a href='/topic/show?id=d34e6523544' target=_blank style='color:#2F92EE;'>#活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65235, encryptionId=d34e6523544, topicName=活检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Fri Jan 06 13:21:00 CST 2017, time=2017-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1386212, encodeId=de8013862122b, content=<a href='/topic/show?id=f08293399f9' target=_blank style='color:#2F92EE;'>#转移性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93399, encryptionId=f08293399f9, topicName=转移性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Fri Jan 06 13:21:00 CST 2017, time=2017-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447006, encodeId=43a3144e006ea, content=<a href='/topic/show?id=549489135c5' target=_blank style='color:#2F92EE;'>#血检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89135, encryptionId=549489135c5, topicName=血检)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc1f5300484, createdName=Luyuxie_11, createdTime=Fri Jan 06 13:21:00 CST 2017, time=2017-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458936, encodeId=fc20145893617, content=<a href='/topic/show?id=53cc8691532' target=_blank style='color:#2F92EE;'>#芯片#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86915, encryptionId=53cc8691532, topicName=芯片)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf76117088, createdName=lixiaol, createdTime=Fri Jan 06 13:21:00 CST 2017, time=2017-01-06, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2010765, encodeId=144a2010e654f, content=<a href='/topic/show?id=98de9341975' target=_blank style='color:#2F92EE;'>#转移性癌症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93419, encryptionId=98de9341975, topicName=转移性癌症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Jan 22 09:21:00 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277998, encodeId=52d412e79982a, content=<a href='/topic/show?id=d34e6523544' target=_blank style='color:#2F92EE;'>#活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65235, encryptionId=d34e6523544, topicName=活检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Fri Jan 06 13:21:00 CST 2017, time=2017-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1386212, encodeId=de8013862122b, content=<a href='/topic/show?id=f08293399f9' target=_blank style='color:#2F92EE;'>#转移性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93399, encryptionId=f08293399f9, topicName=转移性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Fri Jan 06 13:21:00 CST 2017, time=2017-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447006, encodeId=43a3144e006ea, content=<a href='/topic/show?id=549489135c5' target=_blank style='color:#2F92EE;'>#血检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89135, encryptionId=549489135c5, topicName=血检)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc1f5300484, createdName=Luyuxie_11, createdTime=Fri Jan 06 13:21:00 CST 2017, time=2017-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458936, encodeId=fc20145893617, content=<a href='/topic/show?id=53cc8691532' target=_blank style='color:#2F92EE;'>#芯片#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86915, encryptionId=53cc8691532, topicName=芯片)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf76117088, createdName=lixiaol, createdTime=Fri Jan 06 13:21:00 CST 2017, time=2017-01-06, status=1, ipAttribution=)]
    2017-01-06 smlt2008
  3. [GetPortalCommentsPageByObjectIdResponse(id=2010765, encodeId=144a2010e654f, content=<a href='/topic/show?id=98de9341975' target=_blank style='color:#2F92EE;'>#转移性癌症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93419, encryptionId=98de9341975, topicName=转移性癌症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Jan 22 09:21:00 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277998, encodeId=52d412e79982a, content=<a href='/topic/show?id=d34e6523544' target=_blank style='color:#2F92EE;'>#活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65235, encryptionId=d34e6523544, topicName=活检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Fri Jan 06 13:21:00 CST 2017, time=2017-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1386212, encodeId=de8013862122b, content=<a href='/topic/show?id=f08293399f9' target=_blank style='color:#2F92EE;'>#转移性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93399, encryptionId=f08293399f9, topicName=转移性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Fri Jan 06 13:21:00 CST 2017, time=2017-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447006, encodeId=43a3144e006ea, content=<a href='/topic/show?id=549489135c5' target=_blank style='color:#2F92EE;'>#血检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89135, encryptionId=549489135c5, topicName=血检)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc1f5300484, createdName=Luyuxie_11, createdTime=Fri Jan 06 13:21:00 CST 2017, time=2017-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458936, encodeId=fc20145893617, content=<a href='/topic/show?id=53cc8691532' target=_blank style='color:#2F92EE;'>#芯片#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86915, encryptionId=53cc8691532, topicName=芯片)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf76117088, createdName=lixiaol, createdTime=Fri Jan 06 13:21:00 CST 2017, time=2017-01-06, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2010765, encodeId=144a2010e654f, content=<a href='/topic/show?id=98de9341975' target=_blank style='color:#2F92EE;'>#转移性癌症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93419, encryptionId=98de9341975, topicName=转移性癌症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Jan 22 09:21:00 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277998, encodeId=52d412e79982a, content=<a href='/topic/show?id=d34e6523544' target=_blank style='color:#2F92EE;'>#活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65235, encryptionId=d34e6523544, topicName=活检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Fri Jan 06 13:21:00 CST 2017, time=2017-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1386212, encodeId=de8013862122b, content=<a href='/topic/show?id=f08293399f9' target=_blank style='color:#2F92EE;'>#转移性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93399, encryptionId=f08293399f9, topicName=转移性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Fri Jan 06 13:21:00 CST 2017, time=2017-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447006, encodeId=43a3144e006ea, content=<a href='/topic/show?id=549489135c5' target=_blank style='color:#2F92EE;'>#血检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89135, encryptionId=549489135c5, topicName=血检)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc1f5300484, createdName=Luyuxie_11, createdTime=Fri Jan 06 13:21:00 CST 2017, time=2017-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458936, encodeId=fc20145893617, content=<a href='/topic/show?id=53cc8691532' target=_blank style='color:#2F92EE;'>#芯片#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86915, encryptionId=53cc8691532, topicName=芯片)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf76117088, createdName=lixiaol, createdTime=Fri Jan 06 13:21:00 CST 2017, time=2017-01-06, status=1, ipAttribution=)]
    2017-01-06 Luyuxie_11
  5. [GetPortalCommentsPageByObjectIdResponse(id=2010765, encodeId=144a2010e654f, content=<a href='/topic/show?id=98de9341975' target=_blank style='color:#2F92EE;'>#转移性癌症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93419, encryptionId=98de9341975, topicName=转移性癌症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Sun Jan 22 09:21:00 CST 2017, time=2017-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277998, encodeId=52d412e79982a, content=<a href='/topic/show?id=d34e6523544' target=_blank style='color:#2F92EE;'>#活检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65235, encryptionId=d34e6523544, topicName=活检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Fri Jan 06 13:21:00 CST 2017, time=2017-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1386212, encodeId=de8013862122b, content=<a href='/topic/show?id=f08293399f9' target=_blank style='color:#2F92EE;'>#转移性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93399, encryptionId=f08293399f9, topicName=转移性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Fri Jan 06 13:21:00 CST 2017, time=2017-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1447006, encodeId=43a3144e006ea, content=<a href='/topic/show?id=549489135c5' target=_blank style='color:#2F92EE;'>#血检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89135, encryptionId=549489135c5, topicName=血检)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc1f5300484, createdName=Luyuxie_11, createdTime=Fri Jan 06 13:21:00 CST 2017, time=2017-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458936, encodeId=fc20145893617, content=<a href='/topic/show?id=53cc8691532' target=_blank style='color:#2F92EE;'>#芯片#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86915, encryptionId=53cc8691532, topicName=芯片)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf76117088, createdName=lixiaol, createdTime=Fri Jan 06 13:21:00 CST 2017, time=2017-01-06, status=1, ipAttribution=)]
    2017-01-06 lixiaol

相关资讯

ISRD & ATS 2016:胡洁教授谈液体活检在早期肺癌诊断中的价值

2016 年10月14日~16日,由上海梅斯医学承办的“第十二届上海国际呼吸学会暨ATS联合论坛”(ISRD & ATS 2016)在上海展览中心隆重举行。14日下午,复旦大学附属中山医院呼吸科胡洁教授作了题为“液体活检在早期肺癌诊断中的价值”精彩演讲。梅斯小编对胡洁教授的精彩报告进行整理,与大家分享。  上海市呼吸病研究所,复旦大学呼吸病研究所,复旦大学附属中山医

全新“液体活检”芯片可以通过一滴血检测出转移性癌症

伍斯特理工学院的工程师们研究出一种全新的芯片,只需要用癌症患者体内的一滴血就可以检测出确定转移性癌细胞。这一消息的惊人之处就在于其使用简单的方法带来了科技的又一飞跃。根据登载所示,比起现有使用微流体诱捕癌细胞,这一全新的技术更加有效。伍斯特理工学院的的研究小组成员解释说,这一设备就好像一口小井,井底的碳纳米管上附着着抗体,癌细胞来到井底,根据表面标记选择性的连接在抗体上,接着他们制作了名为“外来体

ISRD & ATS 2016:陈良安教授谈肺癌的非手术活检及其它技术进展和评价

10月14日-16日,美国胸科学会(ATS)携手上海市呼吸病研究所联合举办的第十二届国际呼吸学会暨ATS联合论坛(ISRD & ATS 2016)在中国上海展览中心(上海市中心静安区延安中路1000号)隆重召开。作为本届大会的承办单位,梅斯医学也参与了这场呼吸学界的盛会。 15日下午,解放军总医院呼吸科,主任医师陈良安教授在本届大会现场介绍了《肺癌的非手术活检及其它技术进

2016 CSCO液体活检:规范与精准同行

2016年3月4-5日,中国临床肿瘤学会(Chinese Society of Clinical Oncology,CSCO)和中国抗癌协会肺癌专业委员会联合主办了第 13 届“中国肺癌高峰论坛”。本次论坛的主题是“规范与精准同行:液体活检和二代测序步入临床”。2016年肺癌的诊疗悄然进入精准医学的时代。在精准医学的大背景下,液体活检作为一种便捷、微创、能够动态反映肿瘤基因谱全貌的方法在肺癌临床研

ISRD & ATS 2016:胡成平教授谈液体活检及血液检测在肺癌精准诊疗中的应用

2016 年10月14日~16日,由中国健康促进基金会、上海市呼吸病研究所、国际呼吸学会等主办,美国胸科协会(ATS)和复旦大学呼吸病研究所等协办,上海梅斯医学承办的“第十二届上海国际呼吸学会暨ATS联合论坛”(ISRD & ATS 2016)在上海展览中心隆重举行。15日下午,中南大学湘雅医院呼吸与危重症科、中南大学湘雅医院肺癌诊疗中心胡成平教授作了题为“液体活检及血液检测在肺癌精准诊疗

CSCO 2016:“液态活检”如何打开肿瘤早期诊断之窗

凭借一管血检测癌症,这是数十年来全球医学界的共同的梦想。“液体活检”技术,试图用各种技术手段从血液里捕捉相关肿瘤信息,从而规避了传统方式需要手术、穿刺取样的局限性。在日前召开第十九届全国临床肿瘤学大会暨2016年CSCO学术年会上,首都医科大学肺癌诊疗中心主任兼宣武医院胸外科主任支修益教授就“液态活检”(Liquid Biopsy)全国现状进行了总结报告,会后记者采访了支修益教授。梅斯医学:

Baidu
map
Baidu
map
Baidu
map